Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LT-1001 by Lumosa Therapeutics for Post-Operative Pain: Likelihood of Approval
LT-1001 is under clinical development by Lumosa Therapeutics and currently in Phase I for Post-Operative Pain. According to GlobalData, Phase...